MUSTANG BIO, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 95 SAWYER RD, WALTHAM, MA, 02453
Mailing Address 95 SAWYER RD, WALTHAM, MA, 02453
Phone 7816524500
Fiscal Year End 1231
EIN 473828760
Financial Overview
FY2024
-$15.75M
Net Income
$17.74M
Total Assets
$17.62M
Total Liabilities
$123K
Stockholders' Equity
$6.84M
Cash & Equivalents
$-38.57
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13D/A Beneficial ownership amendment | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| DEF 14A Definitive proxy statement | December 3, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 7, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | October 1, 2025 | View on SEC |
| 4 Insider stock transaction report | October 1, 2025 | View on SEC |
Insider Trading
SELL 3 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.